DYANAVEL XR 10 FDA approval date
The FDA approved DYANAVEL XR 10 on 4 Nov 2021.
- FDA approval date
- 4 Nov 2021
- Source
- FDA record
Drug identity has not yet been verified against registry records
Also recorded as AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE
Included trials
No linked trials for this drug yet. Browse all trials
PDUFA dates and FDA decisions
| Date as reported | Drug / company | Event | Condition | Evidence |
|---|---|---|---|---|
| 2021-11-04Day | DYANAVEL XR 10 | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA210526", "applicant_as_listed_by_fda": "TRIS PHARMA INC", "brand_names": ["DYANAVEL XR 10", "DYANAVEL XR 15", "DYANAVEL XR 20", "DYANAVEL XR 5"], "active_ingredients": ["AMPHETAMINE", "AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20211104", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |